Acclaration: Ovasure was pulled out of the market because it did not have marketing clearence or approval from FDA. The Ova sure being marketed by LabCorp was designed, researched and validated by Yale University researches , not LabCorp's
The Test was 95% accurate on 224 blood samples .Thats good enough for me and for many women that would be able to detect if they have ovarian cancer much, much , much earlier than any other method available.
Yes it could have 6% false positives, so what, if the GP or specialist advise of these results to patients and advise them properly ,no women or men would go and get their bits removed without a second or third opinion, but a least this person will know that something has to done after the positive result. If you are one of the 6 % false positive, you'll find out with a follow up. But if your test is really positive .
It looks that HTX is doing the right things , in the right way...... and has a brilliant future IMO and by the way....
no one can patent a screw..... but if you put it together with other screw in a unique way that do a specific job.. then you can patent it
HTX Price at posting:
12.0¢ Sentiment: Hold Disclosure: Held
